Evolution of tumor cells during AsiDNA treatment results in energy exhaustion, decrease in responsiveness to signal, and higher sensitivity to the drug
Abstract It is increasingly suggested that ecological and evolutionary sciences could inspire novel therapies against cancer but medical evidence of this remains scarce at the moment. The Achilles heel of conventional and targeted anticancer treatments is intrinsic or acquired resistance following D...
Main Authors: | Pierre‐Marie Girard, Nathalie Berthault, Maria Kozlac, Sofia Ferreira, Wael Jdey, Srividya Bhaskara, Sergey Alekseev, Frederic Thomas, Marie Dutreix |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Evolutionary Applications |
Subjects: | |
Online Access: | https://doi.org/10.1111/eva.12949 |
Similar Items
-
AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance
by: Wael Jdey, et al.
Published: (2019-09-01) -
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
by: Nirmitha I. Herath, et al.
Published: (2019-11-01) -
Development and Mechanism of Action of the DNA Repair Inhibitor AsiDNA in the Treatment of Medulloblastoma with Radiotherapy
by: Ferreira, Sofia
Published: (2019) -
AsiDNA, a Unique DNA Repair Inhibitor, Triggers Sensitization and Bioenergetic Adaptation in Cancer Cells
by: Kozlak, Maria
Published: (2019) -
Towards accession of Russia to the Convention on Human Rights and Biomedicine
by: E. V. Tarasyants
Published: (2011-06-01)